Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 250 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-07-14 | 2021-07-09 | 120229 |
TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-07-14 | 2020-10-22 | 120232 |
TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-07-14 | 2020-07-15 | 120235 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2020-07-14 | 2021-04-15 | 120238 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2020-07-14 | 2021-04-15 | 120241 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2020-07-14 | 2021-04-15 | 120244 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-07-14 | 2023-04-28 | 120247 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-07-14 | 2023-04-28 | 120250 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-07-14 | 2022-03-26 | 120253 |
TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-03-04 | 120256 |
TEVA-SILDENAFIL R | 20MG | TABLET | Resolved | 2020-07-14 | 2020-07-15 | 120259 |
TEVA-VARENICLINE | 1MG | TABLET | Resolved | 2020-07-14 | 2020-08-04 | 120262 |
TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2020-07-14 | 2020-09-04 | 120271 |
TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2020-07-14 | 2020-09-03 | 120282 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120303 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120306 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120309 |
TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-03-04 | 120312 |
TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-03-04 | 120315 |
TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-07-09 | 120318 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |